News

Unlocking Vision’s Secrets: Researchers Reveal 3D Structure of Key Eye Protein
Researchers have uncovered the 3D structure of RBP3, a key protein in vision, revealing how it transports retinoids and fatty ...
The Globe and Mail27d
Semaglutide, or Ozempic, reduces symptoms of feared diabetes’ complication, study finds
Semaglutide, the medication better known as Ozempic, reduces the symptoms of a condition that can lead to lower limb amputations in people with diabetes, according to a new study that reinforces ...
The New Indian Express7d
India’s first 3D-printed military structure comes up at 11,000 feet in Leh
have successfully delivered India’s first on-site 3D printed protective military structure at a height of 11,000 feet in Leh. This is the world’s highest-ever in-situ 3D printed construction ...
Medical Xpress10d
Adverse events from semaglutide seen in the ED usually gastrointestinal-related
The researchers found that based on 551 cases, there were an estimated 24,499 emergency department visits attributed to semaglutide adverse events in 2022 through 2023 (mean patient age, 50.9 ...
Medscape26d
Semaglutide Shows Major Benefits in Peripheral Arterial Disease: STRIDE
CHICAGO — Semaglutide, a glucagon-like peptide (GLP-1) receptor agonist, has shown convincing benefits in yet another population: patients with peripheral arterial disease (PAD). In the STRIDE ...
Medscape28d
Semaglutide Use Linked to Risk for Vision Loss in Diabetes
The use of semaglutide in patients with diabetes was associated with a significantly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION) compared with those taking drugs for ...
The New England Journal of Medicine27d
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the ...
EurekAlert!27d
Oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar ...
PharmiWeb27d
CPC Announces Semaglutide Significantly Improves Walking Distance, Symptoms and Quality of Life for People with PAD and Diabetes
AURORA, CO / ACCESS Newswire / March 29, 2025 / A novel study of a semaglutide, a glucagon-like peptide-1 (GLP-1) agonist used to treat type 2 diabetes, obesity and cardiovascular disease, semaglutide ...
WAVY-TV14d
Professor Niazi Challenges the 2024 Chemistry Nobel Prize that the 3D Protein Structure cannot be predicted, refuting claims of Rosetta and AlphaFold
Professor Niazi presents a quantum mechanics model to demonstrate that a given amino acid chain can have trillions of possible 3D structures that can never be projected by any chemical testing ...
The Hill29d
Study links Wegovy to increased hair loss risk
Semaglutide is the active ingredient in Wegovy It is also the main component of Ozempic Semaglutide is known to increase the risk of hair loss Semaglutide, the main ingredient in Ozempic and ...
Healthline16d
Compounded Semaglutide the Same as Ozempic?
Compounded semaglutide and Ozempic are different products. While both may be used in people with type 2 diabetes, Ozempic is approved by the FDA, but compounded semaglutide is not. Compounded ...